title: S137 phosphorylation of profilin 1 is an important signaling event in breast cancer progression.
abstract: BACKGROUND
  Profilins are actin-modulating proteins regulating many intracellular functions based on their multiple and diverse ligand interactions. They have been implicated to play a role in many pathological conditions such as allergies, cardiovascular diseases, muscular atrophy, diabetes, dementia and cancer. Post-translational modifications of profilin 1 can alter its properties and subsequently its function in a cell. In the present study, we identify the importance of phosphorylation of profilin 1 at serine 137 (S137) residue in breast cancer progression.
  
  
  RESULTS
  We found elevated profilin 1 (PFN) in human breast cancer tissues when compared to adjacent normal tissues. Overexpression of wild-type profilin 1 (PFN-WT) in breast cancer MCF7 cells made them more migratory, invasive and adherent independent in comparison to empty vector transfected cells. Mutation in serine phosphorylation site (S137) of profilin 1 (PFN-S137A) significantly abrogated these properties. Mutation affecting actin-binding ability (PFN-R74E) of profilin 1 enhanced its tumorigenic function whereas mutation affecting its poly-L-proline binding function (PFN-H133S) alleviated these mechanisms in breast cancer cells. PFN-WT was found to activate matrix metalloproteinases by zymography, MMP2 and MMP9 in presence of PDBu (phorbol 12, 13 dibutyrate, PI3K agonist) to enhance migration and invasion in MCF7 cells while PFN-S137A did not. Phosphorylation increased migration and invasion in other mutants of profilin 1. Nuclear profilin levels also increased in the presence of PDBu.
  
  
  CONCLUSIONS
  Previous studies show that profilin could be executing a dual role in cancer by either suppressing or promoting tumorigenesis in a context dependent manner. In this study we demonstrate for the first time that phosphorylation of profilin 1 at serine 137 enhances oncogenic properties in breast cancer cells. Inhibitors targeting profilin 1 phosphorylation directly or indirectly through inhibition of kinases that phosphorylate profilin could be valuable therapeutic agents that can alter its activity and thereby control the progression of cancer.
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Wasia
authors.initials: W
authors.lastname: Rizwani
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Aneesa
authors.initials: A
authors.lastname: Fasim
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Deepshikha
authors.initials: D
authors.lastname: Sharma
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Divya J
authors.initials: DJ
authors.lastname: Reddy
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Nabil A M
authors.initials: NA
authors.lastname: Bin Omar
authors.affiliation: Department of Biochemistry, Osmania University, Hyderabad, A.P., India.
authors.forename: Surya S
authors.initials: SS
authors.lastname: Singh
mesh_terms: D015153:Blotting, Western; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D066298:In Vitro Techniques; D010766:Phosphorylation / Q000235:genetics / Q000502:physiology; D051304:Profilins / Q000235:genetics / Q000378:metabolism*; D014945:Wound Healing / Q000235:genetics / Q000502:physiology
chemical_list: C495738:PFN1 protein, human; D051304:Profilins
references.citation: Methods Mol Biol. 2012;878:121-35
references.pmid: 22674130
references.citation: Biochem Mol Biol Int. 1998 Oct;46(2):241-8
references.pmid: 9801792
references.citation: Int J Cancer. 2009 Jan 1;124(1):36-45
references.pmid: 18844224
references.citation: Cell Motil Cytoskeleton. 1995;30(1):38-49
references.pmid: 7728867
references.citation: Cell Motil Cytoskeleton. 1997;37(2):166-77
references.pmid: 9186014
references.citation: Clin Cancer Res. 2008 Oct 1;14(19):6246-52
references.pmid: 18829504
references.citation: Amino Acids. 2006 Oct;31(3):289-98
references.pmid: 16547650
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Nitric Oxide. 2006 Feb;14(1):65-71
references.pmid: 16288977
references.citation: Lancet. 2012 Mar 17;379(9820):992-3
references.pmid: 22432152
references.citation: Biochemistry. 1980 Nov 11;19(23):5359-62
references.pmid: 6893804
references.citation: Mol Cancer Ther. 2006 May;5(5):1183-9
references.pmid: 16731750
references.citation: Cell. 1993 Dec 3;75(5):835-8
references.pmid: 8252619
references.citation: J Cell Physiol. 2009 May;219(2):354-64
references.pmid: 19115233
references.citation: J Am Soc Nephrol. 2000 Mar;11(3):423-433
references.pmid: 10703666
references.citation: J Mol Biol. 1977 Sep 25;115(3):465-83
references.pmid: 563468
references.citation: Biochem Biophys Res Commun. 1994 Jan 28;198(2):568-73
references.pmid: 8297366
references.citation: Cell Cycle. 2009 May 15;8(10):1621-9
references.pmid: 19377303
references.citation: Cell. 1994 Oct 21;79(2):303-14
references.pmid: 7954798
references.citation: Nat Cell Biol. 2014 May;16(5):445-56
references.pmid: 24747440
references.citation: Mol Biol Cell. 2004 Apr;15(4):1600-8
references.pmid: 14767055
references.citation: PLoS One. 2012;7(3):e32802
references.pmid: 22479341
references.citation: Proc Natl Acad Sci U S A. 1989 May;86(10):3649-53
references.pmid: 2726742
references.citation: J Biochem. 2005 Dec;138(6):687-95
references.pmid: 16428297
references.citation: Proc Natl Acad Sci U S A. 1987 Nov;84(21):7413-7
references.pmid: 2823261
references.citation: Nat Cell Biol. 2002 Apr;4(4):E91-6
references.pmid: 11944042
references.citation: Science. 1990 Mar 30;247(4950):1575-8
references.pmid: 2157283
references.citation: Mol Biol Cell. 2002 Jul;13(7):2383-96
references.pmid: 12134077
references.citation: Cytometry. 1983 Nov;4(3):211-5
references.pmid: 6198128
references.citation: Mol Cell Biol. 2010 Dec;30(23):5545-61
references.pmid: 20937775
references.citation: Clin Chim Acta. 1999 Sep;287(1-2):59-67
references.pmid: 10509896
references.citation: Breast Cancer Res. 2003;5(1):R1-8
references.pmid: 12559051
references.citation: J Am Soc Nephrol. 2000 Sep;11(9):1620-1630
references.pmid: 10966486
references.citation: Nat Cell Biol. 2012 Oct;14(10):1046-56
references.pmid: 23000962
references.citation: J Cell Sci. 2006 Oct 1;119(Pt 19):4127-37
references.pmid: 16968742
references.citation: Mol Cell Proteomics. 2012 Apr;11(4):M111.009449
references.pmid: 22159600
references.citation: FEBS Lett. 1997 Dec 1;418(3):258-64
references.pmid: 9428724
references.citation: Cancer Res. 1992 Jun 15;52(12):3372-7
references.pmid: 1596895
references.citation: Exp Cell Res. 2009 Oct 15;315(17):2963-73
references.pmid: 19607826
references.citation: Diabetes. 2013 Nov;62(11):3718-26
references.pmid: 23884883
references.citation: J Cell Physiol. 2009 Feb;218(2):436-43
references.pmid: 18937284
references.citation: Recept Signal Transduct. 1996;6(2):77-86
references.pmid: 9015863
references.citation: J Clin Oncol. 2011 Nov 20;29(33):4452-61
references.pmid: 22010023
references.citation: Breast Cancer Res. 2011 May 19;13(3):R52
references.pmid: 21595894
references.citation: Science. 1991 Mar 8;251(4998):1231-3
references.pmid: 1848725
references.citation: Nature. 1985 Apr 4-10;314(6010):472-4
references.pmid: 2984579
references.citation: Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3832-6
references.pmid: 11274401
references.citation: Exp Cell Res. 2003 May 15;286(1):12-21
references.pmid: 12729790
references.citation: Vascul Pharmacol. 2006 May;44(5):275-82
references.pmid: 16524786
references.citation: Biochemistry. 1998 Jun 30;37(26):9274-83
references.pmid: 9649308
references.citation: Proteomics. 2006 Nov;6(22):6107-16
references.pmid: 17051643
references.citation: Biochemistry. 1996 Dec 24;35(51):16544-9
references.pmid: 8987988
references.citation: Int J Biol Macromol. 2009 Oct 1;45(3):265-73
references.pmid: 19523483
references.citation: Blood. 2005 May 15;105(10):3956-64
references.pmid: 15665118
references.citation: Cancer Res. 2005 Feb 15;65(4):1433-41
references.pmid: 15735031
references.citation: EMBO Rep. 2003 May;4(5):523-9
references.pmid: 12776739
references.citation: Cell Signal. 2001 Jun;13(6):433-9
references.pmid: 11384842
references.citation: Nucleus. 2012 May-Jun;3(3):290-9
references.pmid: 22572953
references.citation: Proteomics. 2006 Nov;6(22):6095-106
references.pmid: 17051635
references.citation: Mol Cell Proteomics. 2006 Jan;5(1):157-71
references.pmid: 16215274
references.citation: Curr Cancer Drug Targets. 2008 Dec;8(8):741-52
references.pmid: 19075597
references.citation: Cancer Cell. 2012 Nov 13;22(5):615-30
references.pmid: 23153535
references.citation: Anal Biochem. 1987 Nov 1;166(2):368-79
references.pmid: 2449095
references.citation: Cell Motil Cytoskeleton. 2004 Feb;57(2):84-95
references.pmid: 14691948
references.citation: IUBMB Life. 2012 Jan;64(1):18-26
references.pmid: 22095874
references.citation: J Cell Sci. 1996 Jan;109 ( Pt 1):83-90
references.pmid: 8834793
references.citation: J Cell Sci. 2002 Dec 15;115(Pt 24):4721-6
references.pmid: 12432060
references.citation: Cell Signal. 2004 May;16(5):589-96
references.pmid: 14751544
references.citation: J Exp Med. 2000 May 15;191(10):1675-86
references.pmid: 10811861
references.citation: Hum Reprod. 2006 May;21(5):1143-53
references.pmid: 16428331